Metastatic renal carcinoma comprehensive prognostic system
Open Access
- 10 February 2003
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 88 (3), 348-353
- https://doi.org/10.1038/sj.bjc.6600768
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2002
- IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trialBritish Journal of Cancer, 2001
- Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 1999
- Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinomaBritish Journal of Cancer, 1999
- Prognostic factors for survival in patients with brain metastases from renal cell carcinomaCancer, 1998
- Prognostic Factors for Survival in Patients with Metastatic Renal Cancer Treated with Biological Response ModifiersJournal of Urology, 1995
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignanciesThe Lancet, 1990
- Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariable analysis of the effect of age, stage, histology and blood counts on survivalInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Maximally Selected Chi Square StatisticsBiometrics, 1982